PharmiWeb.com - Global Pharma News & Resources
17-Jun-2019

Joint Pain Injections Market is Projected to Jump USD 5.7 Billion by 2026

Global Joint Pain Injections Market Size is expected to reach USD 5.7 Billion by 2026 and growing CAGR around 8.0% during the forecast period.

The global Joint Pain Injections Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2019 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2019 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/1352

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Joint Pain Injections Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Joint Pain Injections Market market?
  • What is the market drivers, restrains, opportunities governing the global Joint Pain Injections Market Market?
  • Which is the largest and the fastest growing segments in the global Joint Pain Injections Market market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1352

Market Players:

Allergan Plc., Pfizer Inc., Sanofi, Ferring B.V., Flexion Therapeutics, Inc.., Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, and Chugai Pharmaceutical Co., Ltd. are major actors operating on the common pain injections market. Inc. Key players expand their product portfolio by combining, acquiring and cooperating with leading medical firms that are expected to improve the availability of the products and thus boost the market.

The Major Market Segments of GlobalJoint Pain Injections Marketare as below:

Market Segmentation

Market, by Type

  • Hyaluronic Acid Injections
  • Corticosteroid Injections

Market, by Joint Type

  • Knee and Ankle
  • Shoulder and Elbow
  • Hip Joint
  • Facet Joints of the Spine

Market, by Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on Joint Pain Injections Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026offers detailed insights on global Joint Pain Injections market segments with market dynamics and their impact. The report also covers basic technology development policies.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Joint Pain Injections
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Joint Pain Injections Market By Type
1.2.2.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Joint Pain Injections Market Revenue Share By Type in 2017
1.2.2.3. Hyaluronic Acid Injections
1.2.2.4. Corticosteroid Injections
1.2.3. Joint Pain Injections Market By Joint Type
1.2.3.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Joint Type (2015-2026)
1.2.3.2. Global Joint Pain Injections Market Revenue Share By Joint Type in 2017
1.2.3.3. Knee and Ankle
1.2.3.4. Shoulder and Elbow
1.2.3.5. Hip Joint
1.2.3.6. Facet Joints of the Spine
1.2.4. Joint Pain Injections Market By Distribution Channel
1.2.4.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.4.2. Global Joint Pain Injections Market Revenue Share By Distribution Channel in 2017
1.2.4.3. Hospital Pharmacies
1.2.4.4. Online Pharmacies
1.2.4.5. Retail Pharmacies
1.2.5. Joint Pain Injections Market by Geography
1.2.5.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Joint Pain Injections Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Joint Pain Injections Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Joint Pain Injections Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Joint Pain Injections Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Joint Pain Injections Major Manufacturers in 2017

CHAPTER 4. JOINT PAIN INJECTIONS MARKET BY TYPE

4.1. Global Joint Pain Injections Revenue By Type
4.2. Hyaluronic Acid Injections
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Corticosteroid Injections
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. JOINT PAIN INJECTIONS MARKET BY JOINT TYPE

5.1. Global Joint Pain Injections Revenue By Joint Type
5.2. Knee and Ankle
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Shoulder and Elbow
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Hip Joint
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Facet Joints of the Spine
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. JOINT PAIN INJECTIONS MARKET BY DISTRIBUTION CHANNEL

6.1. Global Joint Pain Injections Revenue By Distribution Channel
6.2. Hospital Pharmacies
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Online Pharmacies
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Retail Pharmacies
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA JOINT PAIN INJECTIONS MARKET BY COUNTRY

7.1. North America Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Joint Pain Injections Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Joint Pain Injections Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE JOINT PAIN INJECTIONS MARKET BY COUNTRY

8.1. Europe Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Joint Pain Injections Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET BY COUNTRY

9.1. Asia-Pacific Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Joint Pain Injections Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA JOINT PAIN INJECTIONS MARKET BY COUNTRY

10.1. Latin America Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Joint Pain Injections Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST JOINT PAIN INJECTIONS MARKET BY COUNTRY

11.1. Middle East Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Joint Pain Injections Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA JOINT PAIN INJECTIONS MARKET BY COUNTRY

12.1. Africa Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Joint Pain Injections Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Joint Type, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Allergan Plc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Pfizer Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Sanofi
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Ferring B.V.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Flexion Therapeutics, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Anika Therapeutics, Inc
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. SEIKAGAKU CORPORATION
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Chugai Pharmaceutical Co., Ltd.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Others
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. Key Developments
13.9.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1352

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 17-Jun-2019